|
NCT02281760
|
2014-10-01 |
Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
|
Phase 2
|
Recruiting
|
|
NCT02206477
|
2014-08-01 |
DMSO for Prevention of Capsular Contraction in Alloplastic Breast Reconstruction
|
Phase 2/Phase 3
|
Not Yet Recruiting
|
|
NCT02032134
|
2014-02-01 |
Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia
|
Phase 4
|
Not Yet Recruiting
|
|
NCT02337192
|
2014-01-01 |
Antimicrobial Photodynamic Therapy Applied in Orthodontic. Orthodontic Patients.
|
Phase 1
|
Completed
|
|
NCT01980940
|
2013-12-01 |
The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)
|
Phase 1/Phase 2
|
Completed
|
|
NCT01827384
|
2013-03-01 |
NCI-MPACT: Molecular Profiling-Based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors
|
Phase 2
|
Recruiting
|
|
NCT01725100
|
2013-02-01 |
A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies
|
Phase 1
|
Recruiting
|
|
NCT01442129
|
2012-04-01 |
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation
|
Phase 2
|
Completed
|
|
NCT01123915
|
2010-05-01 |
A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People
|
Phase 1
|
Terminated
|
|
NCT00667095
|
2008-04-01 |
Over Active Bladder Instillation Study - Botox
|
Phase 3
|
Terminated
|
|
NCT00317070
|
2006-04-01 |
Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)
|
Phase 2
|
Terminated
|
|
NCT00583219
|
2006-03-01 |
Botulin-A Toxin Instillations and Overactive Bladder
|
Phase 1/Phase 2
|
Completed
|
|
NCT00118313
|
2004-11-01 |
Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
|
Phase 1
|
Completed
|